Skip to main content
Log in

Eyebrow alopecia associated with cladribine treatment for multiple sclerosis

  • Letter to the Editor
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Cook S, Vermersch P, Comi G et al (2011) Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study. Mult Scler 17:578–593. https://doi.org/10.1177/1352458510391344

    Article  CAS  PubMed  Google Scholar 

  2. Jacobs BM, Ammoscato F, Giovannoni G et al (2018) Cladribine: mechanisms and mysteries in multiple sclerosis. J Neurol Neurosurg Psychiatry 89:1266–1271

    Article  PubMed  Google Scholar 

  3. Thompson AJ, Banwell BL, Barkhof F et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162–173. https://doi.org/10.1016/S1474-4422(17)30470-2 Epub 2017 Dec 21

    Article  PubMed  Google Scholar 

  4. Porwal MH, Salter A, Patel D, Obeidat AZ (2022) Alopecia in multiple sclerosis patients treated with disease modifying therapies. J Cent Nerv Syst Dis 14:11795735221109674. https://doi.org/10.1177/11795735221109674

    Article  PubMed  PubMed Central  Google Scholar 

  5. Rolfes L, Pfeuffer S, Hackert J et al (2021) Skin reactions in patients with multiple sclerosis receiving cladribine treatment. Neurol Neuroimmunol Neuroinflamm 8:e990

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jelena Drulovic.

Ethics declarations

Ethical approval

The study is approved by the Institutional Review Board Clinic of Neurology, University Clinical Center of Serbia.

Informed consent

The patient signed informed consent.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Budimkic, M.S., Ivanovic, J., Momcilovic, N. et al. Eyebrow alopecia associated with cladribine treatment for multiple sclerosis. Neurol Sci 44, 3735–3736 (2023). https://doi.org/10.1007/s10072-023-06874-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-023-06874-x

Navigation